Eric Murphy
Vorstandsvorsitzender bei Alterome Therapeutics, Inc.
Aktive Positionen von Eric Murphy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Eric Murphy
Ehemalige bekannte Positionen von Eric Murphy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | 03.12.2021 | |
| Gründer | 01.01.2018 | 03.12.2021 | |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Eric Murphy
| University of California | Undergraduate Degree |
| University of California Irvine School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Health Technology |
- Börse
- Insiders
- Eric Murphy
- Erfahrung
